FDA SUSAR Reporting Essentials for Sponsors

In this video, we are exploring the essentials of FDA reporting for Serious and Unexpected Suspected Adverse Reactions, or SUSARs - specifically for sponsors conducting clinical trials under an Investigational New Drug application, or IND. We will cover what qualifies as a SUSAR, why timely and accurate reporting is critical, and how to ensure compliance throughout your clinical trial lifecycle.